Vidasym, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2002-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.vidasym.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of VS 105
Phase 1
Completed
- Conditions
- Chronic-kidney Disease Stage 5D on Stable Hemodialysis
- Interventions
- Drug: Single VS-105/placebo to healthyDrug: Multiple VS-105/placebo to healthyDrug: Multiple VS-105/placebo to HD subjects
- First Posted Date
- 2017-02-06
- Last Posted Date
- 2019-10-07
- Lead Sponsor
- Vidasym, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT03043482
- Locations
- 🇺🇸
DaVita Clinical Research, Lakewood, Colorado, United States
News
No news found